FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

7 letters match. Newest first.

  1. onlineotcmeds.com

    FDA warned onlineotcmeds.com for selling unapproved, misbranded opioids, benzodiazepines, and Schedule II stimulants to U.S. consumers online.

    High risk
  2. www.usmedschoice.com

    FDA warned www.usmedschoice.com for selling unapproved and misbranded opioids, benzodiazepines, and stimulants online without prescriptions.

    High risk
  3. Aytu Biopharma

    FDA says Aytu Biopharma’s sponsored links for ADHD drug Cotempla XR-ODT are false or misleading and misbrand it.

    High risk
  4. Aytu Biopharma

    FDA warned Aytu Biopharma that sponsored links for ADHD drug Adzenys XR-ODT are false or misleading because they omit risk information.

    High risk
  5. www.mysteroidsmarket.com

    FDA warns Israel-based website mysteroidsmarket.com for selling unapproved and misbranded stimulants and benzodiazepines to U.S. consumers.

    High risk
  6. Kevin R. Bender, M.D./DBC Research Corporation

    Clinical investigator Kevin R. Bender failed to secure a controlled investigational drug, and 110 kits were stolen.

    High risk
  7. Legacy Pharmaceutical Packaging LLC

    Legacy Pharmaceutical Packaging, a drug repackager, was cited for CGMP violations and insanitary conditions after foreign tablets and floor-picked tablets were found.

    High risk